Corebridge Financial’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,731
Closed -$276K 2998
2025
Q1
$276K Buy
24,731
+47
+0.2% +$520 ﹤0.01% 1884
2024
Q4
$254K Sell
24,684
-1,494
-6% -$14.4K ﹤0.01% 2034
2024
Q3
$248K Buy
26,178
+135
+0.5% +$1.17K ﹤0.01% 2104
2024
Q2
$222K Buy
+26,043
New +$238K ﹤0.01% 2132

Other funds holding ENFN

Corebridge Financial's ENFN Position: Q2 2025 in Review

Corebridge Financial sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 24,731 shares — an estimated $276K sold.

Corebridge Financial first reported a position in ENFN in Q2 2024 and held it in 4 quarters. The position peaked at $276K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Corebridge Financial reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 24,731 Enfusion, Inc. shares in Q2 2025, an estimated $276K.
  • Corebridge Financial first reported a position in Enfusion, Inc. in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Enfusion, Inc. position peaked at $276K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.